Cipla Rashmi Joshi as Independent appointed
Cipla (CIPLA) said Rashmi Joshi as Independent has been appointed. The company is valued at about ₹1.07 lakh crore.
What happened
Cipla (CIPLA) told the exchanges on 27 October 2026 at 01:43 PM that Rashmi Joshi as Independent has been appointed.
From the filing: "Cipla Limited has informed the Exchange regarding Appointment of Ms Rashmi Joshi as Independent Director of the company w.e.f."
Company snapshot
Cipla is a large-cap company in the Healthcare sector, with a market value of about ₹1.07 lakh crore.
The stock last traded at ₹1,322.8, against a 52-week range of ₹1,165.7–₹1,593.8 (17.0% below the high).
Before this filing the shares had moved −3.3% over the month and −5.2% over three months. Average daily turnover over the last 20 sessions was about ₹132 crore.
Promoters held 29.21% at the end of Q1 FY27. Foreign institutions owned 20.21% and domestic institutions 34.63%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 6,957 | 1,297.6 | 16.07 |
| Q2 FY26 | 7,589 | 1,351.2 | 16.73 |
| Q3 FY26 | 7,074 | 675.8 | 8.37 |
| Q4 FY26 | 6,541 | 554.6 | 6.87 |
| Q1 FY27 | 7,119 | 789.1 | 9.77 |
What history shows
This is not the company's first management change disclosure: BCEIE has 6 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 0.3% on average the next trading day and was up 3.6% on average after five days (4 filings with price data).
Across 107 similar disclosures by other Healthcare companies, shares moved +0.9% on average the next day and +1.6% over five days; 48% of them rose the next day.
Market-wide, 4,000 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 22 Sept 2026 | Change in Senior Management Personnel. | +1.1% | — |
| 23 Jul 2026 | Management change | +1.2% | +5.8% |
| 25 Jun 2026 | Change in Auditors of the company. | +1.0% | +1.3% |
| 16 Jun 2026 | Management change | −2.2% | +3.8% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- India's Cipla misses second-quarter profit view on muted US sales
- Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds
- Weekly Recap: Cipla Ltd below 200‑week EMA and MF holdings up 2.6%
- Gaurav Kaul Takes Charge as Managing Director & CEO of Cipla Health Ltd
- Market wrap: Bajaj Finance, Cipla, Nestle India, Eternal top gainers and losers on Nifty and Sensex on Thu
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.